Dabigatran Reversal Agent

Dabigatran Reversal Agent
Jun 25, 2015 7:43am

In a report given at the International Society for Thrombosis and Haemostasis biennial meeting in Toronto, Dr. Charles Pollack indicated that a trial of the Boehringer-Ingelheim drug idarucizumab safely and effectively reversed the effects of dabigatran. To see the full report, select Dabigatran Reversal Agent RE-VERSE AD on Heartwire.


Leave A Comment

You must be logged in to Comment - Sign In